Ingersoll Rand Work in process increased by 25.7% to $161.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.4%, from $109.80M to $161.80M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 15.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.00M | $94.70M | $88.60M | $111.60M | $118.90M | $104.50M | $122.20M | $139.90M | $147.30M | $129.30M | $145.10M | $137.50M | $129.90M | $132.10M | $116.30M | $109.80M | $130.00M | $150.60M | $128.70M | $161.80M |
| QoQ Change | — | +8.9% | -6.4% | +26.0% | +6.5% | -12.1% | +16.9% | +14.5% | +5.3% | -12.2% | +12.2% | -5.2% | -5.5% | +1.7% | -12.0% | -5.6% | +18.4% | +15.8% | -14.5% | +25.7% |
| YoY Change | — | — | — | — | +36.7% | +10.3% | +37.9% | +25.4% | +23.9% | +23.7% | +18.7% | -1.7% | -11.8% | +2.2% | -19.8% | -20.1% | +0.1% | +14.0% | +10.7% | +47.4% |
| % of Inventories | 11.0% | 11.1% | 10.1% | 11.4% | 11.5% | 9.8% | 11.3% | 11.7% | 12.5% | 11.2% | 13.5% | 12.2% | 10.5% | 10.6% | 10.3% | 9.0% | 10.0% | 11.1% | 10.1% | 12.1% |
| Share Change | — | +0.0pp | -1.0pp | +1.3pp | +0.1pp | -1.7pp | +1.5pp | +0.5pp | +0.8pp | -1.4pp | +2.3pp | -1.4pp | -1.7pp | +0.2pp | -0.4pp | -1.2pp | +1.0pp | +1.1pp | -1.0pp | +2.0pp |